thromboxanes has been researched along with Genetic Predisposition in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitzgerald, DJ; Maree, AO | 1 |
| Freedman, JE | 1 |
1 review(s) available for thromboxanes and Genetic Predisposition
| Article | Year |
|---|---|
Aspirin and coronary artery disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Disease; Cyclooxygenase Inhibitors; Drug Resistance; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Models, Biological; Platelet Aggregation; Prostaglandins; Risk Factors; Thrombosis; Thromboxanes | 2004 |
1 other study(ies) available for thromboxanes and Genetic Predisposition
| Article | Year |
|---|---|
Heritability, platelet function, and aspirin: a link established but cause unknown.
Topics: Arachidonic Acid; Aspirin; Black or African American; Blood Platelets; Cardiovascular Diseases; Cyclooxygenase 1; Female; Genetic Heterogeneity; Genetic Predisposition to Disease; Genetic Variation; Humans; Male; Membrane Proteins; Phenotype; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Sex Characteristics; Thrombophilia; Thrombosis; Thromboxanes; White People | 2007 |